Object: The evolution and severity of hydrocephalus in animal models varies in the species and mode of induction. This makes comparisons of the physiological system under investigation difficult between models. We noted that injection of kaolin into neonatal rats results in a dichotomous outcome into either an acute or subacute form. We investigated the clinical and functional transmitter system changes to compare these two types of hydrocephalus evolution. Methods: Hydrocephalus was induced in Wistar neonatal rats (within a week after their birth) by intracisternal injection of 0.02 ml volume of 25% kaolin solution under microscopic guidance. The same volume of sterile saline was injected into 12 neonatal rats as control group. The animals were assigned to either the acute or subacute group according to their head size, and sacrificed at 2, 4 and 8 weeks after injection. Biparietal diameter, ventricular size, cholinergic interneurons in the neostriatum and dopaminergic projection neurons in the substantia nigra were analyzed at each stage. Results: Animals affected with the acute type of hydrocephalus had obvious head enlargement, rapid ventricular enlargement, and all died at about 4 weeks. Animals with subacute type had slowly progressive ventricular enlargement, and all survived until 8 weeks. There appeared to be more kaolin ventral to the brainstem in the acute type. The number of cholinergic neostriatal neurons was significantly reduced at 2 and 4 weeks in the acute type, but only at 8 weeks in the subacute type. The number of dopaminergic nigral neurons was decreased at 4 weeks in the acute type, but unaffected in the subacute type. Conclusions: The severity of onset of hydrocephalus in this animal model also correlates with the clinical outcome and changes in functional transmitter systems.

Keywords:
Neonatal hydrocephalus, Acute and subacute type, Dopamine, Acetylcholine, Immunohistochemical staining
1.
Del Bigio MR, Crook CR, Buist R: Magnetic resonance imaging and behavioral analysis of immature rats with kaolin-induced hydrocephalus: Pre- and postshunting observations. Exp Neurol 1997;148:256–264.
2.
Hale PM, McAllister JP II, Katz SD, Wright LC, Lovely TJ, Miller DW, Wolfson BJ, Salotto AG, Schroff DV: Improvement of cortical morphology in infantile hydrocephalic animals after ventriculoperitoneal shunt placement. Neurosurgery 1992;31:1085–1096.
3.
Drake JM, Potts DG, Lemaire C: Magnetic resonance imaging of silastic-induced canine hydrocephalus. Surg Neurol 1989;31:28–40.
4.
McAllister JP II, Cohen MI, O’Mara KA, Johnson MH: Progression of experimental infantile hydrocephalus and effects of ventriculoperitoneal shunts; an analysis correlating magnetic resonance imaging with gross morphology. Neurosurgery 1991;29:329–340.
5.
Tashiro Y, Drake JM, Chakrabortty S, Hattori T: Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus. Brain Res 1997;770:45–52.
6.
Da Silvia MC, Michowicz S, Drake JM, Chumas PD, Tuor UI: Reduced local cerebral blood flow in periventricular white matter in experimental neonatal hydrocephalus – Restoration with CSF shunting. J Cereb Blood Flow Metab 1995;15:1057–1065.
7.
Del Bigio MR, Bruni JE: Change in periventricular vasculare of rabbit brain following induction of hydrocephalus and after shunting. J Neurosurg 1988;69:115–120.
8.
Chumas PD, Drake JM, Del Bigio MR, Da Silvia MC, Tuor UI: Anaerobic glycolysis preceding white-matter destruction in experimental neonatal hydrocephalus. J Neurosurg 1994;80:491–501.
9.
Da Silvia MC, Drake JM, Lemaire C, Cross A, Tuor UI: High-energy phosphate metabolism in a neonatal model of hydrocephalus before and after shunting. J Neurosurg 1994;81:544–553.
10.
Richards HK, Bucknall RM, Jones HC, Pickard JD: The uptake of [14-C]-deoxyglucose into brain of young rats with inherited hydrocephalus. Exp Neurol 1989;103:194–198.
11.
Wehby-Grant MC, Olmstead CE, Peacock WJ, Hovda DA, Gayek RJ, Fisher RS: Metabolic responses of the neonatal rabbit brain to hydrocephalus and shunting. Pediatr Neurosurg 1996;24:79–91.
12.
Del Bigio MR, Vriend JP: Monoamine neurotransmitters and amino acids in the cerebrum and striatum of immature rats with kaolin-induced hydrocephalus. Brain Res 1998;798:119–126.
13.
Lovely TJ, McAllister JP II, Miller DW, Lamperti AA, Wolfson BJ: Effects of hydrocephalus and surgical decompression on cortical norepinephrine levels in neonatal cats. Neurosurgery 1989;24:43–52.
14.
McAllister JP II, Maugans TA, Shah MV, Truex RC Jr: Neuronal effects of experimentally induced hydrocephalus in newborn rats. J Neurosurg 1985;63:776–783.
15.
Tashiro Y, Chakrabortty S, Drake JM, Hattori T: Progressive loss of glutamic acid decarboxylase, parvalbumin and calbindin D28K immunoreactive neurons in the cerebral cortex and hippocampus of adult rat with experimental hydrocephalus. J Neurosurg 1997;86:263–271.
16.
Wright LC, McAllister JP II, Katz SD, Miller DW, Lovely TJ, Salotto AG, Wolfson BJ: Cytological and cytoarchitectural changes in the feline cerebral cortex during experimental infantile hydrocephalus. Pediatr Neurosurg 1991;16:139–155.
17.
Yamada H, Yokota A, Furuta A, Horie A: Reconstitution of shunted mantle in experimental hydrocephalus. J Neurosurg 1992;76:856–862.
18.
Groves PM: A theory of the functional organization of the neostriatum and the nigrostriatal control of voluntary movement. Brain Res 1983;5:109–132.
19.
Hassler R: Striatal control of locomotion, intentional actions, and integrating and perceptive activity. J Neurol Sci 1978;36:187–224.
20.
Villablanca JR, Marcus RJ, Olmstead CE: Effects of caudate nuclei or frontal cortical ablations in cats. I. Neurology and gross behavior. Exp Neurol 1976;52:389–420.
21.
Marsden CD: Functions of the basal ganglia as revealed by cognitive and motor disorders in Parkinson’s disease. Can J Neurol Sci 1984;11:129–135.
22.
Sonberg PR, Coyle JT: Scientific approaches to Huntington’s disease. CRC Crit Rev Clin Neurobiol 1984;1:1–44.
23.
Chovanes GI, McAllister JP II, Lamperti AA, Salotto RC: Monoamine alternations during experimental hydrocephalus in neonatal rats. Neurosurgery 1988;22:86–91.
24.
Del Bigio MR, Bruni JE: Silicone oil-induced hydrocephalus in the rabbit. Childs Nerv Syst 1991;7:79–84.
25.
Edvinsson L, Nielsen KC, Owman C, Rosengern E, West KA: Concomitant fall in brain dopamine and homovanillic acid in hydrocephalic rabbits. Exp Neurol 1972;37:647–649.
26.
Ehara K, Matsumoto S, Yoshida N, Kuno T, Tanaka C: Ascending norepinephrine pathways impaired in experimental hydrocephalus. Jpn J Pharmacol 1982;32:205–208.
27.
Miwa S, Inagaki C, Fujiwara M, Takaori S: The activities of noradrenergic and dopaminergic neuron systems in experimental hydrocephalus. J Neurosurg 1982;57:67–73.
28.
Del Bigio MR, Kanfer JN, Zhang YW: Myelination delay in the cerebral white matter of immature rats with kaolin-induced hydrocephalus is reversible. J Neuropathol Exp Neurol 1997;56:1053–1166.
29.
Del Bigio MR, Da Silvia MC, Drake JM, Tuor UI: Acute and chronic cerebral white matter damage in neonatal hydrocephalus. Can J Neurol Sci 1994;21:299–305.
30.
Phelips PE, Brady DR, Vaughn JE: The generation and differentiation of cholinergic neurons in the rat caudate-putamen. Dev Brain Res 1989;46:47–60.
31.
Schlossor B, Klausa G, Prime G, Ten Bruggencate G: Postnatal development of calretinin- and parvalbumin positive interneurons in the rat neostriatum: An immunohistochemical study. J Comp Neurol 1999;405:185–198.
32.
Freund TF, Buzsaki G, Leon A, Baimbridge KG, Somogyi P: Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp Brain Res 1990;83:55–56.
33.
Lauder JM; Bloom FE: Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 1974;155:469–481.
34.
Del Bigio MR, Zhang YW: Cell death, axonal damage, and cell birth in the immature rat brain following induction of hydrocephalus. Exp Neurol 1998;154:157–169.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.